Aldosterone-Induced Activation of Signaling Pathways Requires Activity of Angiotensin Type 1a Receptors
- 23 October 2009
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation Research
- Vol. 105 (9), 852-859
- https://doi.org/10.1161/circresaha.109.196576
Abstract
Rationale: Aldosterone has been shown to induce vascular damage, endothelial dysfunction, and myocardial fibrosis, which depend in part on activation of angiotensin II (Ang II)–mediated pathways. However, mechanisms underlying crosstalk between Ang II type 1 receptor (AT1R) and mineralocorticoid receptor (MR) are mostly unknown. Objectives: We tested whether the lack of Ang II type 1a receptor (AT1aR) or Ang II type 1b receptor (AT1bR) would decrease cellular effects induced by aldosterone. Methods and Results: We examined the effect of Ang II or aldosterone after transfection of mesenteric vascular smooth muscle cells (VSMCs) from C57Bl/6 mice with small interference RNA for AT1aR, AT1bR, or MR for 48 hours. Ang II and aldosterone separately induced ERK1/2, c-Jun NH2-terminal protein kinase (JNK), and nuclear factor (NF)-κB phosphorylation after a 20-minute stimulation. Small interference RNA for AT1aR downregulated phosphorylation of ERK1/2, JNK, and NF-κB after aldosterone stimulation compared to controls. Downregulation of AT1bR or MR only abolished the activation of NF-κB. In VSMCs from C57Bl/6 mice, aldosterone and Ang II induced the activation of the c-fos promoter from 30 minutes to 1 hour. This effect was blocked when using VSMCs from AT1aR knockout mice. Conclusion: We show for the first time that nongenomic and genomic effects of aldosterone are differentially dependent on activity of both AT1aR and AT1bR. Our data suggest that aldosterone augments AT1R-dependent activation of ERK1/2, JNK, and NF-κB in VSMCs. We provide mechanistic understanding and experimental in vitro support for the benefit of combination therapy with dual blockade of AT1R and MR to treat hypertension and progression of heart failure as reported in clinical studies and animal models.Keywords
This publication has 24 references indexed in Scilit:
- Vasoconstrictor effect of aldosterone via angiotensin II type 1 (AT1) receptor: possible role of AT1 receptor dimerizationCardiovascular Research, 2008
- New Twist to the Role of the Renin-Angiotensin System in Heart FailureHypertension, 2008
- In vivo regulation of AT1a receptor-mediated intracellular uptake of [125I]Val5-ANG II in the kidneys and adrenals of AT1a receptor-deficient miceAmerican Journal of Physiology-Renal Physiology, 2008
- c-Src–Dependent Nongenomic Signaling Responses to Aldosterone Are Increased in Vascular Myocytes From Spontaneously Hypertensive RatsHypertension, 2005
- Aldosterone and Angiotensin II Synergistically Induce Mitogenic Response in Vascular Smooth Muscle CellsCirculation Research, 2005
- Mechanism for Aldosterone Potentiation of Angiotensin II–Stimulated Rat Arterial Smooth Muscle Cell ProliferationHypertension, 2004
- Mechanical stress activates angiotensin II type 1 receptor without the involvement of angiotensin IINature, 2004
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999
- Effect of aldosterone on vascular angiotensin II receptors in the ratCanadian Journal of Physiology and Pharmacology, 1985
- Vascular angiotensin II receptors in renal and DOCA-salt hypertensive rats.Hypertension, 1983